Delaware Chapter of the American College of CardiologyOur purpose is to contribute to the prevention of cardiovascular diseases, to ensure optimal quality of care for individuals with such diseases, and to foster the highest professional ethical standards. Please let us know what information you want to see here. Feel free to contact us with your ideas, needs and comments. |
|
ACC Live Courses For a listing of all ACC Live Courses please visit: https://www.acc.org/education-and-meetings/meetings |
Latest in Cardiology from ACC.org
- Statins For the Prevention of Anthracycline-Induced Cardiotoxicity: Contextualizing Guideline Recommendations For Clinical PracticeAnthracycline-induced cardiotoxicity is a major contributor to long-term cardiovascular (CV) outcomes in survivors of cancer. Up to 20% of patients exposed to anthracyclines develop irreversible cardiomyopathy through mechanisms leading to cardiomyocyte death.
- PAD Series Spotlights Current Burden, Future ChallengesA three-part series published Sept. 22 in The Lancet underscores the growing global impact of peripheral artery disease (PAD) and reinforces the need for earlier diagnosis, improved treatment and better access to care.
- VPC-Yoga: Structured Yoga Intervention Reduces VPC Burden, Improves QOLIn patients with frequent ventricular premature complexes (VPCs), a structured yoga program compared with standard care reduced VPCs as well as improved quality of life (QOL) and psychological burden, according to results from the single-center, prospective VPC-Yoga study conducted in India and published Sept. 17 in JACC: Advances.
- Variation in Decision Moments and PE Diagnostic Yield in the EDVariation in deciding to test for pulmonary embolism (PE) across emergency department (ED) clinicians was associated with diagnostic yield, according to a retrospective study recently published in JAMA Network Open.
- ACC CardiaCast: Intersections in Dyslipidemia and Cardiometabolic Syndrome ManagementThis episode is part of ACC’s ongoing initiative on implementing the 2026 Dyslipidemia guidelines.



